4[1]Goulis J. Leandro G. Burroughs AK. Randomised controlled trials of ursodeoxycholic acid therapy for pimary biliary cirrosis: a mata-analy-sis. Lancet, 1999,354:1053-1060. 被引量：1
5[2]Corpechot C, Carrat F, Bonnand AM, et al. The detect of ursodeoxzycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology,2000,32: 1196-1199. 被引量：1
6[3]Almasio PL, Floreani A, Chiaramonte M, et al. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicines in symptomatic primary biliary cirrhosis. Aliment Pharmacol Ther, 2000,14:1645-1652. 被引量：1
7[4]Leuschner M, Maier KP, Schlichting J, et al. Oral budesonide and ursodeoxycholicacid for treatment of primary biliary cirrhosis: results of a prospective double blind trial. Gastroenterology. 1999,117:918-925. 被引量：1
8[5]Lindor KD. Ursodiol for primary sclerosing cholangitis. N Eng1 J Med, 1997,336: 691-695. 被引量：1
9[6]van Hoogstraten H J, Vleggaar FP, Boland G J, et al. Budesonide or prednisone in combination with ursodeoxycholi acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Am J Gastroenterol, 2000,95: 2015-2022. 被引量：1
10[7]Gilger MA, Gann ME, Opekun AR, et al. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr, 2000,31: 136-141. 被引量：1
